First Tracks Biotherapeutics Ownership | Who Owns First Tracks Biotherapeutics?
First Tracks Biotherapeutics Ownership Summary
First Tracks Biotherapeutics is owned by 94.39% institutional investors, 8.74% insiders. Ecor1 capital is the largest institutional shareholder, holding 9.14% of TRAX shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 3.14% of its assets in First Tracks Biotherapeutics shares.
TRAX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | First Tracks Biotherapeutics | 94.39% | 8.74% | -3.13% |
| Sector | Healthcare Stocks | 245.07% | 12.10% | -157.17% |
| Industry | Biotech Stocks | 380.48% | 11.73% | -292.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ecor1 capital | 3.17M | 9.14% | $63.87M |
| Tcg crossover management | 2.90M | 8.33% | $58.25M |
| Fmr | 2.05M | 5.91% | $41.33M |
| Affinity asset advisors | 2.03M | 5.85% | $40.88M |
| Blackrock funding, inc. /de | 1.96M | 5.65% | $39.51M |
| Vanguard capital management | 1.45M | 4.18% | $29.21M |
| Vestal point capital, lp | 1.01M | 2.92% | $20.38M |
| Woodline partners lp | 917.18K | 2.64% | $18.45M |
| Sanofi | 821.92K | 2.37% | $16.54M |
| Morgan stanley | 781.53K | 2.25% | $15.72M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ally bridge group (ny) | 284.29K | 5.06% | $5.72M |
| Ecor1 capital | 3.17M | 3.11% | $63.87M |
| Sanofi | 821.92K | 3.10% | $16.54M |
| Stempoint capital lp | 622.72K | 2.16% | $12.53M |
| Affinity asset advisors | 2.03M | 1.85% | $40.88M |
| Palo alto investors lp | 603.49K | 1.68% | $12.14M |
| Tcg crossover management | 2.90M | 1.40% | $58.25M |
| 683 capital management | 750.00K | 0.74% | $15.09M |
| Sofinnova investments | 565.20K | 0.59% | $11.37M |
| Crcm lp | 35.34K | 0.49% | $711.04K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | 3.17M | 3.11% | 3.17M |
| Tcg crossover management | 2.90M | 1.40% | 2.90M |
| Fmr | 2.05M | 0.00% | 2.05M |
| Affinity asset advisors | 2.03M | 1.85% | 2.03M |
| Blackrock funding, inc. /de | 1.96M | 0.00% | 1.96M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tfc financial management | 1.00 | - | 1.00 |
| Ifp advisors | 1.00 | - | 1.00 |
| Integrated wealth concepts | 3.00 | - | 3.00 |
| Clearstead advisors | 3.00 | - | 3.00 |
| Stone house investment management | 3.00 | - | 3.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ecor1 capital | 3.17M | 3.11% | 3.17M | $63.87M |
| Tcg crossover management | 2.90M | 1.40% | 2.90M | $58.25M |
| Fmr | 2.05M | 0.00% | 2.05M | $41.33M |
| Affinity asset advisors | 2.03M | 1.85% | 2.03M | $40.88M |
| Blackrock funding, inc. /de | 1.96M | 0.00% | 1.96M | $39.51M |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 149 | - | 32,799,201 | - | 94 | - | 149 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 1.11M | 3.14% | 342.90K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.11M | 3.14% | - |
| State Street® SPDR® S&P® Biotech ETF | 915.92K | 2.59% | 2.11K |
| iShares Russell 2000 ETF | 594.78K | 1.68% | -10.56K |
| FIAM Small Cap Core CIT Cl B | 515.20K | 1.46% | 55.89K |
| Fidelity Select Health Care | 400.00K | 1.13% | - |
| Fidelity Advisor Biotechnology I | 341.15K | 0.96% | 192.75K |
| Vanguard Institutional Extnd Mkt Idx Tr | 309.77K | 0.88% | 575.00 |
| Federated Hermes Kaufmann Small Cap A | 290.00K | 0.82% | 290.00K |
| Federated Hermes Kaufmann Small Cap Grow | 290.00K | 0.82% | 290.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
TRAX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools